1. Home
  2. ADVM vs FLNT Comparison

ADVM vs FLNT Comparison

Compare ADVM & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • FLNT
  • Stock Information
  • Founded
  • ADVM 2006
  • FLNT 2001
  • Country
  • ADVM United States
  • FLNT United States
  • Employees
  • ADVM N/A
  • FLNT N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • FLNT Advertising
  • Sector
  • ADVM Health Care
  • FLNT Consumer Discretionary
  • Exchange
  • ADVM Nasdaq
  • FLNT Nasdaq
  • Market Cap
  • ADVM 47.4M
  • FLNT 39.2M
  • IPO Year
  • ADVM 2014
  • FLNT N/A
  • Fundamental
  • Price
  • ADVM $2.25
  • FLNT $1.87
  • Analyst Decision
  • ADVM Strong Buy
  • FLNT Hold
  • Analyst Count
  • ADVM 5
  • FLNT 1
  • Target Price
  • ADVM $26.40
  • FLNT $3.00
  • AVG Volume (30 Days)
  • ADVM 186.4K
  • FLNT 21.6K
  • Earning Date
  • ADVM 08-11-2025
  • FLNT 08-18-2025
  • Dividend Yield
  • ADVM N/A
  • FLNT N/A
  • EPS Growth
  • ADVM N/A
  • FLNT N/A
  • EPS
  • ADVM N/A
  • FLNT N/A
  • Revenue
  • ADVM $1,000,000.00
  • FLNT $243,850,000.00
  • Revenue This Year
  • ADVM N/A
  • FLNT N/A
  • Revenue Next Year
  • ADVM $18.82
  • FLNT $11.62
  • P/E Ratio
  • ADVM N/A
  • FLNT N/A
  • Revenue Growth
  • ADVM N/A
  • FLNT N/A
  • 52 Week Low
  • ADVM $1.78
  • FLNT $1.50
  • 52 Week High
  • ADVM $10.14
  • FLNT $3.83
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 40.11
  • FLNT 45.96
  • Support Level
  • ADVM $2.21
  • FLNT $1.78
  • Resistance Level
  • ADVM $3.10
  • FLNT $1.90
  • Average True Range (ATR)
  • ADVM 0.22
  • FLNT 0.09
  • MACD
  • ADVM -0.00
  • FLNT 0.02
  • Stochastic Oscillator
  • ADVM 4.49
  • FLNT 51.85

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

Share on Social Networks: